EyePoint Pharma - EYPT Net earnings per one share for the last twelve months

Official company branding of EyePoint Pharmaceuticals Inc (EYPT)

The success of EyePoint Pharmaceuticals (EYPT) relies on regulatory verdicts regarding new drugs, as clearly demonstrated by the annual percentage change in EPS TTM. Currently, -33.00 represents the latest level value. EyePoint Pharmaceuticals (EYPT) aims to replace painful injections for AMD with the Durasert system, establishing a robust patent barrier through its unique microcapsule technology for sustained drug release.

EYPT EyePoint Pharma: Net earnings per share (EPS TTM) in the range 02/11/2024 - 11/14/2026

EyePoint Pharma - analytical breakdowns and key metrics (EYPT)

- price and consensus price forecast:
Market Price eyepointpharma.com|EYPT - Analyst Consensus Forecast
- issuer market value details:
Market Value EyePoint Pharmaceuticals Inc|EYPT - Total Company Value
- company book value details:
Net Assets per Share EyePoint Pharmaceuticals|EYPT - Book Capitalization|Market-to-Book Ratio eyepointpharma.com|EYPT - Cumulative Company Assets
- debt and liquidity data:
Debt to Capital EyePoint Pharmaceuticals|EYPT - Long-Term Debt to Capital|Current Liabilities to Capital EyePoint Corp|EYPT - Company Debts|Debts to Book Capitalization Ratio EyePoint Pharmaceuticals Inc|EYPT - Company Long-Term Debt|Short-Term Debt EyePoint Pharmaceuticals|Interim Coverage Ratio eyepointpharma.com
- business earnings and investment ratios data:
EYPT - Company Net Income|Net Profit Forecast EyePoint Pharmaceuticals|EYPT - Price to Earnings Ratio|Market Cap to Future Earnings Ratio EyePoint Pharmaceuticals Inc|EYPT - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation EyePoint Pharmaceuticals Inc|EYPT - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months EyePoint Pharmaceuticals|EYPT - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months eyepointpharma.com|EYPT - Earnings growth in current year|Earnings growth forecast for next year EyePoint Pharmaceuticals
- sales and revenue indicators:
EYPT - Company Revenue|Company Future Revenue eyepointpharma.com|EYPT - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple EyePoint Pharmaceuticals Inc
Initial company analysis:eyepointpharma.com
Core merchandise of EyePoint Pharmaceuticals, Inc.

This indicator captures the percentage change in net income per share over a rolling year, allowing investors to assess the actual profitability dynamics of the business. By analyzing the annual growth of EPS TTM, one can track the sensitivity of the market capitalization to the efficiency of the proprietary Durasert technology and the patent protection of new ophthalmological drugs, which determine the future financial results of EyePoint Pharmaceuticals (EYPT).

Competitor analysis

Net earnings per one share for the last twelve months alcon.com|BLCO: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Glaukos Corp (GKOS)|Earnings per share for the last twelve months Apellis Pharmaceuticals Inc|belitebio.com (BLTE) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) OCUL|HROW - Net earnings per one share for the last twelve months|Viridian Therapeutics, Inc. - Net earnings per share for the last 12 months|LENZ Therapeutics Inc (LENZ) - Net earnings per one share for the last twelve months|Oculis Pharma - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Kodiak Corp|aldeyra.com (ALDX) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months KALA (KALA BIO)|Earnings per share for the last twelve months Opus Genetics, Inc.|Net earnings per one share for the last twelve months OKYO Pharma Inc OKYO|Net earnings per share (EPS TTM) ADVM|Net earnings per share for the last four quarters Outlook Therapeutics Corp|Earnings per share for the last twelve months Clearside Biomedical CLSD|NBY: Earnings per share for the last 12 months|KPRX: Net earnings per share for the last 12 months|Alimera Sciences - Earnings per share for the last four quarters|EYEN (eyenovia.com) - Net earnings per share for the last 12 months|Guardion Health - Earnings per share for the trailing year|Earnings per share for the last twelve months Ocuphire Pharma, Inc.|opthea.com - Earnings per one share for the last 12 months